✦ LIBER ✦

PNP8: A MARKOV MODEL OF TREATMENT OF NEWLY DIAGNOSED EPILEPSY IN THE UK—AN ASSESSMENT OF COST-EFFECTIVENESS OF TOPIRAMATE

✍ Scribed by E Remak; J Hutton; M Price; K Peeters; I Adriaenssen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Markov model of treatment of newly dia

✍ E. Remák; J. Hutton; M. Price; K. Peeters; I. Adriaenssen 📂 Article 📅 2003 🏛 Springer 🌐 French ⚖ 315 KB

NP3 A COST-UTILITY MODEL OF TREATMENT OF

✍ E Remák; B Steinhoff 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

NDI: COST-EFFECTIVENESS OF TOPIRAMATE AS

✍ E Remak; J Hutton; M Price; K Peeters; I Adriaenssen 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

CN2 COST-EFFECTIVENESS OFTEMOZOLOMIDE FO

✍ CA Uyl-de Groot; LM Lamers; M Al; M Bent van den; T Gorlia; R Crott; W Mason; R 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PGU14: MODELLING OF AN ANTIOBESITY TREAT

✍ C Knight; A Ratcliffe; P Howard; N Snee; C Farina 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

PCN78 The Cost-Effectiveness of Temozolo

✍ Messali, A.; Hay, J.; Villacorta, R. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB